Annual Cash & Cash Equivalents
$757.57 M
-$97.20 M-11.37%
31 December 2023
Summary:
Teradyne annual cash & cash equivalents is currently $757.57 million, with the most recent change of -$97.20 million (-11.37%) on 31 December 2023. During the last 3 years, it has fallen by -$156.55 million (-17.13%). TER annual cash & cash equivalents is now -32.49% below its all-time high of $1.12 billion, reached on 31 December 2021.TER Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$510.04 M
+$88.13 M+20.89%
29 September 2024
Summary:
Teradyne quarterly cash and cash equivalents is currently $510.04 million, with the most recent change of +$88.13 million (+20.89%) on 29 September 2024. Over the past year, it has dropped by -$126.92 million (-19.93%). TER quarterly cash and cash equivalents is now -54.55% below its all-time high of $1.12 billion, reached on 31 December 2021.TER Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TER Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.4% | -19.9% |
| 3 y3 years | -17.1% | -52.8% |
| 5 y5 years | -18.3% | -14.1% |
TER Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.5% | at low | -54.5% | +20.9% |
| 5 y | 5 years | -32.5% | at low | -54.5% | +20.9% |
| alltime | all time | -32.5% | >+9999.0% | -54.5% | >+9999.0% |
Teradyne Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $510.04 M(+20.9%) |
| June 2024 | - | $421.90 M(-40.4%) |
| Mar 2024 | - | $707.40 M(-6.6%) |
| Dec 2023 | $757.57 M(-11.4%) | $757.57 M(+18.9%) |
| Sept 2023 | - | $636.96 M(+3.9%) |
| June 2023 | - | $613.21 M(-5.5%) |
| Mar 2023 | - | $649.21 M(-24.0%) |
| Dec 2022 | $854.77 M(-23.8%) | $854.77 M(+20.3%) |
| Sept 2022 | - | $710.75 M(+24.3%) |
| June 2022 | - | $572.02 M(-28.0%) |
| Mar 2022 | - | $794.60 M(-29.2%) |
| Dec 2021 | $1.12 B(+22.8%) | $1.12 B(+4.0%) |
| Sept 2021 | - | $1.08 B(+13.1%) |
| June 2021 | - | $954.44 M(+14.8%) |
| Mar 2021 | - | $831.15 M(-9.1%) |
| Dec 2020 | $914.12 M(+18.1%) | $914.12 M(-3.3%) |
| Sept 2020 | - | $945.18 M(+30.3%) |
| June 2020 | - | $725.43 M(+22.2%) |
| Mar 2020 | - | $593.49 M(-23.3%) |
| Dec 2019 | $773.92 M(-16.5%) | $773.92 M(+30.3%) |
| Sept 2019 | - | $593.94 M(+20.0%) |
| June 2019 | - | $495.11 M(+2.4%) |
| Mar 2019 | - | $483.73 M(-47.8%) |
| Dec 2018 | $926.75 M(+115.6%) | $926.75 M(+13.8%) |
| Sept 2018 | - | $814.02 M(+69.5%) |
| June 2018 | - | $480.38 M(-24.7%) |
| Mar 2018 | - | $637.87 M(+48.4%) |
| Dec 2017 | $429.84 M(+39.6%) | $429.84 M(+2.7%) |
| Sept 2017 | - | $418.68 M(-30.0%) |
| June 2017 | - | $598.35 M(+84.3%) |
| Mar 2017 | - | $324.75 M(+5.5%) |
| Dec 2016 | $307.88 M(+16.3%) | $307.88 M(+3.3%) |
| Sept 2016 | - | $297.94 M(-21.8%) |
| June 2016 | - | $381.10 M(+19.3%) |
| Mar 2016 | - | $319.36 M(+20.6%) |
| Dec 2015 | $264.70 M(-10.0%) | $264.70 M(-10.0%) |
| Sept 2015 | - | $294.22 M(-2.2%) |
| June 2015 | - | $300.69 M(+37.3%) |
| Mar 2015 | - | $218.94 M(-25.6%) |
| Dec 2014 | $294.26 M(-13.9%) | $294.26 M(+39.0%) |
| Sept 2014 | - | $211.70 M(-16.9%) |
| June 2014 | - | $254.63 M(+9.5%) |
| Mar 2014 | - | $232.63 M(-31.9%) |
| Dec 2013 | $341.64 M(+0.8%) | $341.64 M(-40.4%) |
| Sept 2013 | - | $572.87 M(+151.7%) |
| June 2013 | - | $227.60 M(-25.4%) |
| Mar 2013 | - | $305.22 M(-9.9%) |
| Dec 2012 | $338.92 M(-40.9%) | $338.92 M(-30.2%) |
| Sept 2012 | - | $485.69 M(-17.5%) |
| June 2012 | - | $589.06 M(+10.4%) |
| Mar 2012 | - | $533.40 M(-7.0%) |
| Dec 2011 | $573.74 M(+44.3%) | $573.74 M(-47.6%) |
| Sept 2011 | - | $1.10 B(+140.5%) |
| June 2011 | - | $455.40 M(+8.4%) |
| Mar 2011 | - | $420.27 M(+5.7%) |
| Dec 2010 | $397.74 M(-4.6%) | $397.74 M(-8.3%) |
| Sept 2010 | - | $433.92 M(+7.4%) |
| June 2010 | - | $404.00 M(+18.1%) |
| Mar 2010 | - | $342.01 M(-17.9%) |
| Dec 2009 | $416.74 M(+29.1%) | $416.74 M(+2.5%) |
| Sept 2009 | - | $406.74 M(+21.7%) |
| June 2009 | - | $334.08 M(+19.7%) |
| Mar 2009 | - | $279.06 M(-13.5%) |
| Dec 2008 | $322.70 M(-42.6%) | $322.70 M(+10.3%) |
| Sept 2008 | - | $292.57 M(+2.3%) |
| June 2008 | - | $286.09 M(-11.4%) |
| Mar 2008 | - | $323.08 M(-42.6%) |
| Dec 2007 | $562.37 M(-1.0%) | $562.37 M(+31.1%) |
| Sept 2007 | - | $429.08 M(+9.1%) |
| June 2007 | - | $393.21 M(-3.1%) |
| Mar 2007 | - | $405.59 M(-28.6%) |
| Dec 2006 | $568.02 M | $568.02 M(-24.8%) |
| Sept 2006 | - | $755.03 M(+124.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2006 | - | $336.52 M(+4.3%) |
| Mar 2006 | - | $322.78 M(-5.3%) |
| Dec 2005 | $340.70 M(+62.9%) | $340.70 M(+47.9%) |
| Sept 2005 | - | $230.34 M(+15.7%) |
| June 2005 | - | $199.06 M(+4.8%) |
| Mar 2005 | - | $190.01 M(-9.1%) |
| Dec 2004 | $209.15 M(-8.4%) | $209.15 M(-20.8%) |
| Sept 2004 | - | $264.02 M(+17.7%) |
| June 2004 | - | $224.34 M(+0.6%) |
| Mar 2004 | - | $222.97 M(-2.4%) |
| Dec 2003 | $228.44 M(-9.2%) | $228.44 M(+22.2%) |
| Sept 2003 | - | $187.00 M(-21.4%) |
| June 2003 | - | $237.90 M(+8.2%) |
| Mar 2003 | - | $219.88 M(-12.6%) |
| Dec 2002 | $251.52 M(-20.8%) | $251.52 M(-13.1%) |
| Sept 2002 | - | $289.36 M(-7.3%) |
| June 2002 | - | $312.29 M(+47.8%) |
| Mar 2002 | - | $211.35 M(-33.5%) |
| Dec 2001 | $317.59 M(+31.0%) | $317.59 M(+181.7%) |
| Sept 2001 | - | $112.76 M(-21.7%) |
| June 2001 | - | $144.04 M(-16.0%) |
| Mar 2001 | - | $171.46 M(-29.3%) |
| Dec 2000 | $242.42 M(+33.7%) | $242.42 M(+6.8%) |
| Sept 2000 | - | $227.09 M(+39.1%) |
| June 2000 | - | $163.25 M(+25.4%) |
| Mar 2000 | - | $130.19 M(-28.2%) |
| Dec 1999 | $181.30 M(-2.3%) | $181.30 M(+49.6%) |
| Sept 1999 | - | $121.20 M(-15.4%) |
| June 1999 | - | $143.28 M(-26.8%) |
| Mar 1999 | - | $195.76 M(+5.5%) |
| Dec 1998 | $185.50 M(+148.3%) | $185.50 M(+41.3%) |
| Sept 1998 | - | $131.26 M(+95.0%) |
| June 1998 | - | $67.31 M(+104.5%) |
| Mar 1998 | - | $32.91 M(-55.9%) |
| Dec 1997 | $74.70 M(-62.9%) | $74.70 M(-13.1%) |
| Sept 1997 | - | $85.98 M(+85.0%) |
| June 1997 | - | $46.48 M(-49.3%) |
| Mar 1997 | - | $91.69 M(-54.5%) |
| Dec 1996 | $201.45 M(+10.6%) | $201.45 M(-30.9%) |
| Sept 1996 | - | $291.56 M(+42.7%) |
| June 1996 | - | $204.35 M(+19.1%) |
| Mar 1996 | - | $171.59 M(-5.8%) |
| Dec 1995 | $182.16 M(-0.4%) | $182.16 M(-22.2%) |
| Sept 1995 | - | $234.19 M(+60.9%) |
| June 1995 | - | $145.52 M(-1.4%) |
| Mar 1995 | - | $147.52 M(-19.3%) |
| Dec 1994 | $182.81 M(+27.3%) | $182.81 M(+26.5%) |
| Sept 1994 | - | $144.54 M(-3.9%) |
| June 1994 | - | $150.35 M(+17.5%) |
| Mar 1994 | - | $127.97 M(-10.9%) |
| Dec 1993 | $143.60 M(+113.1%) | $143.60 M(+6.4%) |
| Sept 1993 | - | $135.00 M(+16.4%) |
| June 1993 | - | $116.00 M(+22.2%) |
| Mar 1993 | - | $94.90 M(+40.8%) |
| Dec 1992 | $67.40 M(+90.4%) | $67.40 M(+6.8%) |
| Sept 1992 | - | $63.10 M(+21.1%) |
| June 1992 | - | $52.10 M(+44.7%) |
| Mar 1992 | - | $36.00 M(+1.7%) |
| Dec 1991 | $35.40 M(+378.4%) | $35.40 M(+58.7%) |
| Sept 1991 | - | $22.30 M(+537.1%) |
| June 1991 | - | $3.50 M(-22.2%) |
| Mar 1991 | - | $4.50 M(-39.2%) |
| Dec 1990 | $7.40 M(+89.7%) | $7.40 M(+289.5%) |
| Sept 1990 | - | $1.90 M(-74.0%) |
| June 1990 | - | $7.30 M(+32.7%) |
| Mar 1990 | - | $5.50 M(+41.0%) |
| Dec 1989 | $3.90 M(-64.2%) | $3.90 M(+11.4%) |
| Sept 1989 | - | $3.50 M(-67.9%) |
| Dec 1988 | $10.90 M(-1.8%) | $10.90 M(-1.8%) |
| Dec 1987 | $11.10 M(-66.5%) | $11.10 M(-66.5%) |
| Dec 1986 | $33.10 M(+33.5%) | $33.10 M(+33.5%) |
| Dec 1985 | $24.80 M(+3000.0%) | $24.80 M(+3000.0%) |
| Dec 1984 | $800.00 K | $800.00 K |
FAQ
- What is Teradyne annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Teradyne?
- What is Teradyne annual cash & cash equivalents year-on-year change?
- What is Teradyne quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Teradyne?
- What is Teradyne quarterly cash and cash equivalents year-on-year change?
What is Teradyne annual cash & cash equivalents?
The current annual cash & cash equivalents of TER is $757.57 M
What is the all time high annual cash & cash equivalents for Teradyne?
Teradyne all-time high annual cash & cash equivalents is $1.12 B
What is Teradyne annual cash & cash equivalents year-on-year change?
Over the past year, TER annual cash & cash equivalents has changed by -$97.20 M (-11.37%)
What is Teradyne quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TER is $510.04 M
What is the all time high quarterly cash and cash equivalents for Teradyne?
Teradyne all-time high quarterly cash and cash equivalents is $1.12 B
What is Teradyne quarterly cash and cash equivalents year-on-year change?
Over the past year, TER quarterly cash and cash equivalents has changed by -$126.92 M (-19.93%)